SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-030789
Filing Date
2018-12-13
Accepted
2018-12-13 08:08:24
Documents
1
Period of Report
2018-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3364
  Complete submission text file 0000899243-18-030789.txt   4660
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 01824
Business Address
Amello Jason (Reporting) CIK: 0001451805 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36352 | Film No.: 181232196

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1